The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
A definitive model for predicting absolute risk of coronary heart disease (CHD) in male and female people with Type II diabetes is not yet available. This paper provides an equation for estimating the risk of new CHD events in people with Type II diabetes, based on data from 4540 U.K. Prospective Diabetes Study male and female patients. Unlike previously published risk equations, the model is diabetes-specific and incorporates glycaemia, systolic blood pressure and lipid levels as risk factors, in addition to age, sex, ethnic group, smoking status and time since diagnosis of diabetes. All variables included in the final model were statistically significant (P<0.001, except smoking for which P=0.0013) in likelihood ratio testing. This model provides the estimates of CHD risk required by current guidelines for the primary prevention of CHD in Type II diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The lower the CAD risk, the higher the chance of a false positive”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [248]
In the citing paper
“During the entire follow-up period, the rate of death among patients in the conventionaltherapy group was 50%, a finding that underscores the poor prognosis for such patients in the absence of intensive treatment.20”
From Effect of a multifactorial intervention on mortality in type 2 diabetes (2008) · cites this paper as [20]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023
Self-citationStratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Self-citationPrevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Cited by
Items 301–400 of 1,000
Jiao, F. F., Fung, C. S. C., Wong, C. K. H., Wan, Y. F., Dai, D., Kwok, R., & Lam, C. L. K. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0127-6 · Cited by 50
Self-rated health and mortality in individuals with diabetes mellitus: prospective cohort study
Wennberg, P., Rolandsson, O., Jerdén, L., Boeing, H., Sluik, D., Kaaks, R., Teucher, B., Spijkerman, A. M. W., Bueno-de-Mesquita, B. H., Dethlefsen, C., et al. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000760 · Cited by 55
Donsa, K., Spat, S., Beck, P., Pieber, T. R., & Holzinger, A. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-16226-3_10 · Cited by 60
“A practical application of risk factor studies is the development of risk assessment models (UKPDS model [62], Framingham model [63]).”
MethodClinical practice guideline for cardiovascular risk management in the Netherlands.
Smulders, Y. M., Burgers, J. S., Scheltens, T., van Hout, B. A., Wiersma, T., & Simoons, M. L. (2008) · PubMed · Cited by 63
Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes
Wells, B. J., Jain, A., Arrigain, S., Yu, C., Rosenkrans, W. A., & Kattan, M. W. (2008) · Diabetes Care · doi:10.2337/dc08-1047 · Cited by 51
Santos‐Oliveira, R., Purdy, C., da Silva, M. P., Carneiro-Leão, A. M. D. A., Machado, M., & Einarson, T. R. (2011) · Diabetologia · doi:10.1007/s00125-011-2078-8 · Cited by 51
“After reading the full text, there were 26 potentially acceptable studies that were rejected at the final stage: 14 did not have appropriate data [1, 13–25]; four did not involve outcomes of interest [26–29]; three studied non-relevant populations [30–32]; three were duplicates [33–35]; and two were editorials/review…”
Backgroundon behalf of the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes (IDACO) Investigators, Sehestedt, T. B., Hansen, T. W., Li, Y., Richart, T., Boggia, J. G., Kikuya, M., Thijs, L., Stolarz‐Skrzypek, K., Casiglia, E., et al. (2011) · Hypertension Research · doi:10.1038/hr.2011.6 · Cited by 51
Area-based socioeconomic status, type 2 diabetes and cardiovascular mortality in Scotland
on behalf of the Scottish Diabetes Research Network (SDRN) Epidemiology Group, Jackson, C. A., Jones, N. R. V., Walker, J. J., Fischbacher, C. M., Colhoun, H. M., Leese, G. P., Lindsay, R. S., McKnight, J. A., Morris, A. D., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2667-1 · Cited by 50
“Current predictive models for coronary heart disease in people with diabetes include factors such as age, sex, smoking status, glycaemic control, cholesterol and blood pressure [14, 15], but do not include SES.”
BackgroundJazet, I. M., de Craen, A. J. M., van Schie, E. M., & Meinders, A. E. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.10.019 · Cited by 54
Welschen, L. M. C., Bot, S. D. M., Kostense, P. J., Dekker, J. M., Timmermans, D. R. M., van der Weijden, T., & Nijpels, G. (2012) · Diabetes Care · doi:10.2337/dc11-2130 · Cited by 48
“risk perception was assessed by calculating the agreement between the UKPDS score (estimation of risk of developing CVD including nine variables: age at diagnosis, duration of diabetes, sex, ethnicity, smoking status, systolic blood pressure, HbA1c, total cholesterol, and HDL cholesterol) (23) of the patient and the p…”
Bannister, C. A., Poole, C., Jenkins‐Jones, S., Morgan, C. L., Elwyn, G. J., Spasić, ., & Currie, C. J. (2013) · Diabetes Care · doi:10.2337/dc13-1159 · Cited by 53
Coronary artery calcification score and carotid intima–media thickness in patients with hemophilia
Zwiers, M., Lefrandt, J. D., Mulder, D. J., Smit, A. J., Gans, R. O. B., Vliegenthart, R., Brands‐Nijenhuis, A. V. M., Kluin‐Nelemans, H. C., & Meijer, K. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04514.x · Cited by 51
Diabetes and Coronary Risk Equivalency
Grundy, S. M. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1904 · Cited by 53
Balducci, S., Haxhi, J., Sacchetti, M., Orlando, G., Cardelli, P., Vitale, M., Mattia, L., Iacobini, C., Bollanti, L., Conti, F., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1505 · Cited by 50
Hageman, S. H. J., Dorresteijn, J. A. N., Pennells, L. A. M., van Smeden, M., Bots, M. L., Angelantonio, E. D., & Visseren, F. L. J. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad202 · Cited by 52
Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion
van den Oever, I. A., van Sijl, A. M., & Nurmohamed, M. T. (2013) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x13491025 · Cited by 58
Asimakopoulou, K. G., Skinner, T. C., Spimpolo, J., Marsh, S., & Fox, C. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2007.12.007 · Cited by 50
Comparison of cardiovascular disease risk calculators
Allan, G. M., Garrison, S., & McCormack, J. P. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000095 · Cited by 55
“Still others are derived from randomized controlled trial databases [24] or diabetic patients only [25].”
BackgroundMatuschik, L., Riabov, V., Schmuttermaier, C., Sevastyanova, T. N., Weiß, C., Klüter, H., & Kzhyshkowska, J. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031385 · Cited by 52
Validation of the UKPDS 82 risk equations within the Cardiff Diabetes Model
McEwan, P., Ward, T., Bennett, H., & Bergenheim, K. (2015) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-015-0038-8 · Cited by 50
Young, J. B., Gauthier‐Loiselle, M., Bailey, R. A., Manceur, A. M., Lefèbvre, P., Greenberg, M., Lafeuille, M., Duh, M. S., Bookhart, B., & Wysham, C. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0759-z · Cited by 52
Deep Learning for Predictive Analytics in Healthcare
Muniasamy, A., Tabassam, S., Hussain, M. A., Sultana, H., Muniasamy, V., & Bhatnagar, R. (2019) · Advances in intelligent systems and computing · doi:10.1007/978-3-030-14118-9_4 · Cited by 64
Jamthikar, A. D., Gupta, D., Khanna, N. N., Araki, T., Saba, L., Nicolaides, A. N., Sharma, A., Omerzu, T., Suri, H. S., Gupta, A. K., et al. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0788-4 · Cited by 52
Davis, W. A., Colagiuri, S., & Davis, T. M. E. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02343.x · Cited by 59
Park, G., Lee, S., Cho, Y., Kim, C. J., Cho, J. S., Park, M., Her, S., Ahn, J., Lee, J., Park, D., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.11.028 · Cited by 49
“A CAD risk was calculated from nonfatal and fatal CAD 10-year risk scores by the UK Prospective Diabetes Study (UKPDS) risk engine.(14) Multidetector computed tomographic angiography was performed using a dual-source scanner (Somatom Definition, Siemens, Germany), with the following acquisition parameters: tube voltag…”
MethodKhanna, N. N., Jamthikar, A. D., Gupta, D., Nicolaides, A. N., Araki, T., Saba, L., Cuadrado‐Godia, E., Sharma, A., Omerzu, T., Suri, H. S., et al. (2019) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2019.01.002 · Cited by 49
Cabrera, C. S., Lee, A. S., Olsson, M., Schnecke, V., Westman, K., Lind, M., Greasley, P. J., & Skrtic, S. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.07.029 · Cited by 51
“Smoker (yes) n (%) 3387 (11) 981 (12) 740 (10) 696 (10) 970 (12) 189 (11) 64 (14) 35 (12) 269 (12)”
Tougaard, N. H., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, T. S., Hansen, T. W., Rossing, P. R., & Frimodt‐Møller, M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017165 · Cited by 50
“Median (interquartile range) albumin excretion rate was 17 (17-63) mg/24 h.”
BackgroundHallén, J., Johansen, O. E., Birkeland, K. I., Gullestad, L. L., Aakhus, S., Endresen, K., Tjora, S., Jaffe, A. S., & Atar, D. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-52 · Cited by 49
“Estimation of 10-year risk for coronary artery disease was performed using the UK Prospective Diabetes Study risk algorithm [15], a diabetes-specific model that incorporates HbA1c, systolic blood pressure total and HDL cholesterol, atrial fibrillation, age, gender, ethnic group, smoking status and duration of diabetes.”
MethodAl Hamarneh, Y. N., Hemmelgarn, B. R., Hassan, I., Jones, C. A., & Tsuyuki, R. T. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.08.244 · Cited by 36
Hamarneh, Y. N. A., Johnston, K., Marra, C. A., & Tsuyuki, R. T. (2019) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163519851822 · Cited by 47
Ackermann, R. T., Thompson, T. J., Selby, J. V., Safford, M. M., Stevens, M., Brown, A. F., & Narayan, K. M. V. (2006) · Diabetes Care · doi:10.2337/dc06-0633 · Cited by 47
“*Difference in 10-year predicted probability of a CHD event (24,25).”
BackgroundHealth- related quality of life in diabetic people with different vascular risk
Oliva, J., Fernández-Bolaños, A., & Hidalgo‐Vega, Á. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-812 · Cited by 54
Beswick, A. D., Brindle, P., Fahey, T. P., & Ebrahim, S. B. J. (2008) · Europe PMC (PubMed Central) · Cited by 67
Masuda, S., Tamura, K., Wakui, H., Kanaoka, T., Ohsawa, M., Maeda, A., Dejima, T., Yanagi, M., Azuma, K., & Umemura, S. (2009) · Hypertension Research · doi:10.1038/hr.2009.131 · Cited by 46
Vascular Protection in People with Diabetes
Stone, J. A., Fitchett, D., Grover, S. A., Lewanczuk, R. Z., & Lin, P. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.030 · Cited by 49
Usefulness of total cholesterol/HDL‐cholesterol ratio in the management of diabetic dyslipidaemia
Gimeno-Orna, J. A., Faure-Nogueras, E., & Sancho‐Serrano, M. A. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01341.x · Cited by 54
Zgibor, J. C., Ruppert, K. M., Orchard, T. J., Soedamah‐Muthu, S. S., Fuller, J., Chaturvedi, N., & Roberts, M. S. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.02.009 · Cited by 50
Nilsson, P. M., Cederholm, J., Eeg‐Olofsson, K., Eliasson, B., Zethelius, B., Fagard, R. H., rnsdottir, S. G., & Register, F. T. S. N. D. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32832ccc50 · Cited by 48
Raikou, M., McGuire, A. J., Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., Neil, H. A. W., Livingstone, S. J., Charlton-Menys, V., Fuller, J., et al. (2007) · Diabetologia · doi:10.1007/s00125-006-0561-4 · Cited by 48
Cosson, E., Nguyen, M. T., Chanu, B., Banu, I., Chiheb, S., Balta, C., Takbou, K., & Valensi, P. E. (2011) · Diabetes Care · doi:10.2337/dc11-0480 · Cited by 48
Crasto, W., Jarvis, J., Khunti, K., Skinner, T. C., Gray, L. J., Brela, J., Troughton, J., Daly, H., Lawrence, I. G., McNally, P. G., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.05.008 · Cited by 45
Vaccaro, O., Boemi, M., Cavalot, F. L., Feo, P. D., Miccoli, R., Patti, L., Rivellese, A. A., Trovati, M., Ardigò, D., & Zavaroni, I. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.10.026 · Cited by 49
“For analytical purposes 10 year CHD risk was calculated according to the UKPDS risk engine [11].”
MethodSon, J. W., Jang, E.-H., Kim, M., Kim, I. T., Roh, Y., Baek, K., Song, K., Yoon, K., Cha, B., Lee, K., et al. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.11.005 · Cited by 48
Quality of Care for Patients With Type 2 Diabetes in Primary Care in Norway Is Improving
Cooper, J. G., Claudi, T., Jenum, A. K., Thue, G., Hausken, M. F., Ingskog, W., & Sandberg, S. (2009) · Diabetes Care · doi:10.2337/dc08-0605 · Cited by 44
“The UK Prospective Diabetes Study riskengine model (3) was used to calculate the 10-year risk reduction for coronary disease.”
MethodFakhrzadeh, H., Sharifi, F., Alizadeh-Khoei, M., Arzaghi, S. M., Tajalizadekhoob, Y., Tootee, A., Alatab, S., Mirarefin, M., Badamchizade, Z., & Kazemi, H. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-016-0263-5 · Cited by 48
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
Chawla, R., Madhu, S. V., Makkar, B. M., Ghosh, S. K., Saboo, B., Kalra, S., & On behalf of RSSDI-ESI Consensus Group (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00819-2 · Cited by 57
Greiver, M., Havard, A., Bowles, J., Kalia, S., Chen, T., Aliarzadeh, B., Moineddin, R., Sherlock, J., Hinton, W., Sullivan, F., et al. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x714089 · Cited by 46
“48 Expanding the use of newer medications more rapidly in younger populations presumed to be at lower risk may dilute the overall effect.”
Predicting Cardiovascular Risk in Type 2 Diabetes: the Heterogeneity Challenges
Gore, M. O., McGuire, D. K., Lingvay, I., & Rosenstock, J. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0607-7 · Cited by 48
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 84
Wu, W., Taveira, T. H., Jeffery, S. M., Jiang, L., Tokuda, L., Musial, J., Cohen, L. B., & Uhrle, F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195898 · Cited by 44
Predicting Coronary Risk in UK South Asians: An Adjustment Method for Framingham-Based Tools
Aarabi, M., & Jackson, P. R. (2005) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000159279.88814.aa · Cited by 44
van der Heijden, A. A. W. A., Riet, E. V. ‘., Bot, S. D. M., Cannegieter, S. C., Stehouwer, C. D. A., Baan, C. A., Dekker, J. M., & Nijpels, G. (2013) · Diabetes Care · doi:10.2337/dc12-2691 · Cited by 43
Mason, J. E., England, D., Denton, B. T., Smith, S. A., Kurt, M., & Shah, N. D. (2011) · Medical Decision Making · doi:10.1177/0272989x11404076 · Cited by 50
Nolan, T., Dack, C., Pal, K., Ross, J., Stevenson, F. A., Peacock, R., Pearson, M. G., Spiegelhalter, D. J., Sweeting, M. J., & Murray, E. (2015) · British Journal of General Practice · doi:10.3399/bjgp15x683953 · Cited by 48
Fadini, G. P., Zatti, G., Baldi, I., Bottigliengo, D., Consoli, A., Giaccari, A., Sesti, G., Avogaro, A., & for the DARWIN‐T2D network (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13280 · Cited by 45
“For each group, we estimated the expected improvement in cardiovascular risk using the UK Prospective Diabetes Study risk engine.(14) Patients initiated on dapagliflozin showed the most consistent and significant reduction in the estimated 10-year risk of coronary heart disease, fatal coronary heart disease, stroke an…”
MethodEffect of carotid image-based phenotypes on cardiovascular risk calculator: AECRS1.0
Khanna, N. N., Jamthikar, A. D., Gupta, D., Araki, T., Piga, M., Saba, L., Carcassi, C., Nicolaides, A. N., Laird, J. R., Suri, H. S., et al. (2019) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-019-01975-2 · Cited by 44
the Sentinel Practice Network of the Basque Country, Piniés, J. A., González-Carril, F., Arteagoitia, J. M., Irigoien, I., Altzibar, J. M., Rodriguez-Murua, J. L., & Echevarriarteun, L. (2014) · Diabetologia · doi:10.1007/s00125-014-3370-1 · Cited by 48
Portnoy, D. B., Kaufman, A. R., Klein, W. M. P., Doyle, T. A., & de Groot, M. (2013) · Journal of Risk Research · doi:10.1080/13669877.2013.794153 · Cited by 47
“…from CHD, demographic and other medical data from the questionnaire (Pennsylvania sample), or through medical record review (Ohio Sample), were entered into the risk engine developed as part of the United Kingdom Prospective Diabetes Study (http://www. dtu.ox.ac.uk/riskengine; Stevens et al. 2001).”
MethodPalmer, A. J., Roze, S., Valentine, W. J., Smith, I., & Wittrup-Jensen, K. U. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904x5661 · Cited by 47
Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus
Maetzel, A., Ruof, J., Covington, M., & Wolf, A. (2003) · PharmacoEconomics · doi:10.2165/00019053-200321070-00005 · Cited by 56
Chen, L., Peeters, A., Magliano, D. J., Shaw, J. E., Welborn, T. A., Wolfe, R. S., Zimmet, P., & Tonkin, A. M. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32816f7739 · Cited by 43
Welschen, L. M., van Oppen, P., Dekker, J. M., Bouter, L. M., Stalman, W. A., & Nijpels, G. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-74 · Cited by 42
“These included weight, height, waist circumference, blood pressure, fasting blood glucose, HbA1c, triglycerides (at baseline and 12 months only), total cholesterol (at baseline and 12 months only) and HDL-cholesterol (at baseline and 12 months only).”
InfluentialPalmer, J. L., Gibbs, M., Scheijbeler, H., Kotchie, R. W., Nielsen, S., White, J. R., & Valentine, W. J. (2008) · Advances in Therapy · doi:10.1007/s12325-008-0080-4 · Cited by 43
The structure of optimal statin initiation policies for patients with Type 2 diabetes
Kurt, M., Denton, B. T., Schaefer, A. J., Shah, N. D., & Smith, S. A. (2011) · IIE Transactions on Healthcare Systems Engineering · doi:10.1080/19488300.2010.550180 · Cited by 47
“Consistent with the results of randomized clinical trials and the parameter estimates of Stevens et al. (2001) and Kothari et al. (2004), we assume that β7, γ5 ≥ 1, i.e.,LR is a positive risk factor for a CHD or a stroke event.”
MethodResultInfluentialA Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes
Tran‐Duy, A., Knight, J., Palmer, A. J., Petrie, D., Lung, T. W.-C., Herman, W. H., Eliasson, B., Svensson, A., & Clarke, P. (2020) · Diabetes Care · doi:10.2337/dc19-2249 · Cited by 48
Lee, S., Zhou, J., Guo, C. L., Wong, W. T., Liu, T., Wong, I. C. K., Jeevaratnam, K., Zhang, Q., & Tse, G. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.240 · Cited by 44
Czoski‐Murray, C., Warren, E., Chilcott, J. B., Beverley, C., Psyllaki, M., & Cowan, J. (2004) · Health Technology Assessment · doi:10.3310/hta8130 · Cited by 50
Yates, T., Griffin, S., Bodicoat, D. H., Brierly, G., Dallosso, H., Davies, M. J., Eborall, H., Edwardson, C., Gillett, M., Gray, L., et al. (2015) · Trials · doi:10.1186/s13063-015-0813-z · Cited by 39
Dalakleidi, K., Zarkogianni, K., Thanopoulou, A., & Nikita, K. (2017) · Expert Systems · doi:10.1111/exsy.12214 · Cited by 37
“Risk prediction models for long ‐ term diabetes complications have been mainly focused on CVD and diabetic retinopathy (Brown et al., 2000; Skevofilakas, Zarkogianni, Karamanos, & Nikita, 2010; Stevens et al., 2001; Zarkogianni et al., 2015a).”
BackgroundMendes, R., Sousa, N., Reis, V. M., & Themudo-Barata, J. L. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14091057 · Cited by 46
Cardiovascular disease in type 1 diabetes
Sharma, H., Lencioni, M., & Narendran, P. (2019) · Cardiovascular endocrinology & metabolism · doi:10.1097/xce.0000000000000167 · Cited by 32
Cuadrado‐Godia, E., Jamthikar, A. D., Gupta, D., Khanna, N. N., Araki, T., Maniruzzaman, M., Saba, L., Nicolaides, A. N., Sharma, A., Omerzu, T., et al. (2019) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2019.03.020 · Cited by 43
The UKPDS and its global impact
GENUTH, S. M. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02504.x · Cited by 44
Goldfine, A. B. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32830c6c37 · Cited by 43
Lipscomb, E. R., Finch, E. A., Brizendine, E., Saha, C. K., Hays, L. M., & Ackermann, R. T. (2009) · Diabetes Care · doi:10.2337/dc08-1622 · Cited by 41
“of values among patients with diabetes (11,12).”
MethodResultRattik, S., Engelbertsen, D., Wigren, M., Ljungcrantz, I., Östling, G., Persson, M., Fredrikson, G. N., Bengtsson, E., Nilsson, J. Å., & Björkbacka, H. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118817942 · Cited by 41
Sheppard, J. P., Fletcher, K., McManus, R. J., & Mant, J. (2013) · British Journal of General Practice · doi:10.3399/bjgp14x676447 · Cited by 47
“Cholesterol measured 10 339 (30) 9022 (73) 1176 (46)”
Microvascular disease and cardiovascular outcomes among individuals with type 2 diabetes
Kazé, A. D., Santhanam, P., Erqou, S. A., Bertoni, A. G., Ahima, R. S., & Echouffo-Tcheugui, J. B. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108859 · Cited by 45
Rosland, A.-M., Piette, J. D., Trivedi, R., Lee, A., Stoll, S., Youk, A. O., Obrosky, D. S., Deverts, D., Kerr, E. A., & Heisler, M. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.37960 · Cited by 35
NHG-Standaard Cardiovasculair risicomanagement
Wiersma, T., Boukes, F., Geijer, R. M. M., & Goudswaard, A. N. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6614-9_6 · Cited by 41
Sibal, L., Neely, R. D. G., Jones, A. F., & Home, P. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02888.x · Cited by 46
von Scholten, B. J., Reinhard, H., Hansen, T. W., Lindhardt, M. K., Petersen, C. L., Wiinberg, N., Hansen, P. R., Parving, H., Jacobsen, P. K., & Rossing, P. R. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0225-0 · Cited by 40
Cost-Effectiveness of a Quality Improvement Collaborative Focusing on Patients With Diabetes
Schouten, L., Niessen, L. W., van de Pas, J. W. A. M., Grol, R. P. T. M., & Hulscher, M. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181eb318f · Cited by 42
“We used the individual risk factor values and diabetes control measurements in both trial groups to calculate the overall change in the annual risks of cardiovascular events and cardiovascular deaths (United Kingdom Prospective Diabetes Study UKPDS score; Table 1).(25,26)”
MethodDiabetes Self-management Education Program for Medicaid Recipients
Balamurugan, A., Ohsfeldt, R. L., Hughes, T. E., & Phillips, M. M. (2006) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721706294787 · Cited by 40
“Risks are based primarily on changes in lipids and blood pressure.(20,21) Unfortunately, lipid values were not collected for the program participants.”
BackgroundPrognostication — The lost skill of medicine
Kellett, J. G. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.09.002 · Cited by 46
Madsen, S. M., Thorup, A. C. S., Overgaard, K., Bjerre, M., & Jeppesen, P. B. (2015) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2015.1087033 · Cited by 41
“Cardiovascular disease risk assessment score In here, we applied the Framingham (D’Agostino RB et al., 2008) and the United Kingdom Prospective Diabetes Study (UKPDS) (Stevens et al., 2001) risk assessment models to predict cardiovascular disease risks prior to and following the HIIT intervention.”
MethodInfluentialHoerger, T. J., Zhang, P., Segel, J. E., Gregg, E. W., Narayan, K. M. V., & Hicks, K. A. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.09.017 · Cited by 40
“Prospective Diabetes Study (UKPDS) [14–17].”
Farmer, A. A., Stevens, R., Hirst, J. A., Lung, T. W.-C., Oke, J. L., Clarke, P., Glasziou, P., Neil, A., Dunger, D. B., Colhoun, H. M., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18140 · Cited by 44
“Utility values were obtained from a meta-analysis of diabetes studies and, where some diabetic complications were not reported, further published data from the UKPDS.”
MethodSelf-citationPrediction and classification of cardiovascular disease risk in older adults with diabetes
Mukamal, K. J., Kizer, J. R., Djoussé, L., Ix, J. H., Zieman, S. J., Siscovick, D. S., Sibley, C. T., Tracy, R. P., & Arnold, A. M. (2012) · Diabetologia · doi:10.1007/s00125-012-2772-1 · Cited by 42
Adler, A., Lévy, J., Matthews, D. R., STRATTON, I. M., Hines, G., & Holman, R. R. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01418.x · Cited by 42
Self-citationPaynter, N. P. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.351 · Cited by 38
Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes
Reinhard, H., Jacobsen, P. K., Lajer, M., Pedersen, N. B., Billestrup, N., Mandrup-Poulsen, T. R., Parving, H. ‐., & Rossing, P. R. (2010) · Diabetologia · doi:10.1007/s00125-010-1843-4 · Cited by 38
“The 10 year UK Prospective Diabetes Study (UKPDS) CHD/stroke risk engine scores were calculated in all patients at baseline and after 30 and 90 days [6].”
MethodKhunti, K., Skinner, T. C., Heller, S. R., Carey, M., Dallosso, H. M., Davies, M. J., & Collaborative, O. B. O. T. D. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02620.x · Cited by 43
UKPDS—modelling of cardiovascular risk assessment and lifetime simulation of outcomes
Adler, A. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02498.x · Cited by 45
Self-citationKim, C.-J., Kim, D.-J., & Park, H.-R. (2011) · Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e3181ec02ae · Cited by 35
“0.(16) The UKPDS defines CVD as the first to occur of myocardial infarction, sudden cardiac death, other incidents of ischemic heart disease, stroke, or peripheral vascular disease death.”
BackgroundMackness, B., McElduff, P., & Mackness, M. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01554.x · Cited by 38
Basu, S., Millett, C. J., Vijan, S. S., Hayward, R. A., Kinra, S., Ahuja, R., & Yudkin, J. S. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001827 · Cited by 38
“The risk equations in this model provide estimates of disease progression rates with and without treatment, including 20-y probabilities of heart disease events (including ischemic heart disease, myocardial infarction, and heart failure), stroke, blindness, diabetic ulcer (from peripheral arterial disease or neuropath…”
BackgroundMethodInfluentialCotugno, M., Nosso, G., Saldalamacchia, G., Tadini, G. V., Griffo, E., Lupoli, R., Angrisani, L., Riccardi, G., & Capaldo, B. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0644-5 · Cited by 37
Stewart, M. W., Cirkel, D. T., Furuseth, K., Donaldson, J., Biswas, N., Starkie, M. G., Phenekos, C., & Hamann, A. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01942.x · Cited by 38
Metadata
- Authors
- STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M.
- Affiliations
- University of Oxford (GB)
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2001-12-01
- Volume
- 101
- Issue
- 6
- Pages
- 671
- ISSN
- 0143-5221 (ISSN-L)
- OpenAlex
- W2117191092
- Cited by
- 1,084
- References
- 51
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 10 · 2023: 33 · 2022: 44 · 2021: 60 · 2020: 46 · 2019: 42 · 2018: 47 · 2017: 42 · 2016: 39 · 2015: 60 · 2014: 66 · 2013: 68 · 2012: 59
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- coronary artery disease, type 2 diabetes, cardiovascular risk prediction, risk prediction model, glycemia, systolic blood pressure, serum lipids, primary prevention, smoking, sex differences
- MeSH terms
- Adult, Blood Pressure, Coronary Disease, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Lipids, Male, Middle Aged, Risk Factors, Smoking, Models, Statistical, Survival Rate, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.